A detailed history of Innovis Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Innovis Asset Management LLC holds 22,505 shares of VRTX stock, worth $10.7 Million. This represents 3.01% of its overall portfolio holdings.

Number of Shares
22,505
Previous 22,539 0.15%
Holding current value
$10.7 Million
Previous $7.93 Billion 1.33%
% of portfolio
3.01%
Previous 2.93%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$338.18 - $362.46 $11,498 - $12,323
-34 Reduced 0.15%
22,505 $7.83 Billion
Q2 2023

Aug 03, 2023

BUY
$314.42 - $351.91 $1.25 Million - $1.4 Million
3,969 Added 21.37%
22,539 $7.93 Billion
Q1 2023

May 10, 2023

BUY
$283.23 - $323.1 $1.56 Million - $1.77 Million
5,493 Added 42.01%
18,570 $5.85 Billion
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $3.74 Million - $4.2 Million
13,077 New
13,077 $3.78 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Innovis Asset Management LLC Portfolio

Follow Innovis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innovis Asset Management LLC with notifications on news.